2026 Binaytara Dallas Conference: Cellular Therapies for Cancer and Beyond – The Next Frontier

08:25 AM - 08:45 AM

Updates in CAR T-cell therapy for Aggressive Lymphomas (DLBCL, MCL): SOC and Emerging Constructs – Elif Yilmaz, MD

08:45 AM - 09:05 AM

CAR T-Cell Therapy in Indolent Lymphomas (FL) and CLL/SLL – Bradley Christensen, MD

09:05 AM - 09:25 AM

Role for Stem cell Transplantation and Emerging Cellular Therapies in T-cell Lymphomas (PTCL and CTCL) – Swaminathan Padmanabhan Iyer, MD

09:25 AM - 09:40 AM

Panel Discussion – Moshe Yair Levy, MD; Elif Yilmaz, MD; Bradley Christensen, MD; Swaminathan Padmanabhan Iyer, MD

09:55 AM - 10:15 AM

How to best incorporate CAR T in Adult ALL? – Vivian Irizarry Gatell, MD

10:15 AM - 10:35 AM

Emerging Cellular Therapies and Role of Allogeneic SCT in AML – Clayton Jackson, MD

10:35 AM - 10:50 AM

Panel Discussion – Vivian Irizarry Gatell, MD; Clayton Jackson, MD

10:50 AM - 11:15 AM

What to Expect for the Next Decade in Cellular Therapies? – Sattva S Neelapu, MD

11:15 AM - 11:30 AM

Q&A

12:30 PM - 12:50 PM

Emerging Role of Auto Stem Cell Transplantation in Multiple Myeloma: For All or for Some? – Adeel Khan, MD, MS, MPH

12:50 PM - 01:10 PM

Optimal Timing of CAR T-Cell Therapy in Multiple Myeloma: Current Evidence and Future Directions – Aimaz Afrough, MD

01:10 PM - 01:30 PM

Immunotherapy for Relapsed Multiple Myeloma: CAR T-Cell Therapy or Bispecific Antibodies First? – Sean Maximillian Taasan, MD

01:30 PM - 01:45 PM

Panel Discussion – Samer Al Hadidi, MD; Adeel Khan, MD, MS, MPH; Aimaz Afrough, MD; Sean Maximillian Taasan, MD

01:45 PM - 02:05 PM

Identificaton and Management of CAR T-related Toxicities – John Mathews, MD

02:05 PM - 02:25 PM

From Community Oncology to CAR T-centers and back: Navigating Brain-to-vein time, Logistics and Survivorship – Carolina Escobar, MD

02:25 PM - 02:45 PM

Improving Accessibility and Sustainability of Cellular Therapy – Richard T. Maziarz, MD

02:45 PM - 03:00 PM

Panel Discussion – John Mathews, MD; Carolina Escobar, MD

03:20 PM - 03:40 PM

Immunotherapy for Rheumatologic and other Autoimmune Diseases: Current Evidence and Future Directions – Luis Pineiro, MD

03:40 PM - 04:00 PM

Gene Therapies for SCD, Thalassemia and Beyond – Jean-Antoine Ribeil, MD, PhD

04:00 PM - 04:20 PM

Cellular Therapy for Solid Tumors – Jaehyuk Choi, MD, PhD